Analyst price target on bg. Nasdaq updated dec 4, 2021 12:51 am.
Shares of viking therapeutics, inc.
Vktx stock forecast zacks. Get the latest chart with broker recommendations from zacks investment research. (vktx) could be a good stock pick from a technical perspective. Zacks' 7 best strong buy stocks for december, 2021.
Based on 1 wall street analysts offering 12 month price targets for bunge in the last 3 months. Management provides update on 2021 outlook. The average price target represents a 155.10% change from the last price of $5.88.
Their forecasts range from $13.00 to $21.00. The average price target is $89.00 with a high forecast of $89.00 and a low forecast of $89.00. After reaching an important support level, viking therapeutics, inc.
Moreover, vktx currently has a zacks rank #2 (buy), which means it is in the top 20% of more than the 4,000 stocks that we rank based on. Based on 5 wall street analysts offering 12 month price targets for ngm biopharmaceuticals in the last 3 months. Find the latest viking therapeutics, inc.
The biotechnology company reported ($0.17) eps for the quarter, beating the consensus estimate of ($0.21) by $0.04. Which stocks will be december's top performers? Vktx | complete viking therapeutics inc.
Viking therapeutics last posted its quarterly earnings data on november 3rd, 2021. This suggests a possible upside of 174.6% from the stock's current price. The average price target is $30.25 with a high forecast of $32.00 and a low forecast of $27.00.
Multiple milestones upcoming in 2021 based on our probability adjusted dcf model that takes into account potential future revenues of vk5211, vk2809, and vk0214, vktx is valued at $22/share. The average price target represents a 36.88% change from the last price of $22.10. In fact, when combining a zacks rank #3 or better and a positive earnings esp, stocks produced a positive surprise 70% of.
(vktx) stock quote, history, news and other vital information to help you with your stock trading and investing. On average, they expect viking therapeutics' stock price to reach $15.57 in the next year. The company currently sits at a #2 (buy) on the zacks rank, also indicating that the stock could be poised for a breakout.
(vktx) have gained 1.5% over the past four weeks to close the last trading session at $6.14, but there could still be. These stocks gained 30.7% in 2020 through december 14th and still beat the market by 15.8 percentage points. We recently spoke to the management team at viking therapeutics, inc.
Analyst price target on vktx. Moreover, vktx currently has a zacks rank #2 (buy), which means it is in the top 20% of more than the 4,000 stocks that we rank based on trends in earnings estimate revisions and eps surprises. The technique has proven to be very useful for finding positive surprises.
Zacks' 7 best strong buy stocks for december, 2021. (nasdaq:vktx), including ceo brian lian, regarding the outlook for the company in. The highest, average, and lowest price.
Viking therapeutics has generated ($0.71) earnings per share over the last year ( ($0.71) diluted earnings per share). The average price target represents a 17.66% change from the last price of $75.64. The average price target is $15.00 with a high forecast of $18.00 and a low forecast of $13.00.
Hedge funds were also right about betting on vktx as the stock returned 15.3% since the. Over the past four weeks, vktx has gained 8.5%. Based on 7 wall street analysts offering 12 month price targets for viking therapeutics in the last 3 months.
